Cascade Investment Advisors, Inc. Astrazeneca PLC Transaction History

Cascade Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $31,575 - $35,800	500 New	500 $34,000
Q2 2021 Aug 04, 2021	SELL	$48.42 - $60.18 $4,842 - $6,018	-100 Reduced 16.67%	500 $29,000
Q3 2019 Oct 22, 2019	SELL	$40.12 - $45.47 $7,141 - $8,093	-178 Reduced 22.88%	600 $26.7 Million
Q4 2017 Jan 17, 2018	BUY	$32.09 - $34.78 $24,966 - $27,058	778	778 $27 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.